1 |
Dion I, Rouais F, Baquey C, Lahaye M, Salmon R, Trut L, Cazorla JP, Huong PV, Monties JR, Havlik P. Physico-chemistry and cytotoxicity of ceramics: part I: characterization of ceramic powders. J Mater Sci Mater Med 1997;8:325-32.
DOI
|
2 |
Ito A, Tateishi T, Niwa S, Tange S. In-vitro evaluation of the cytocompatibility of wear particles generated by UHMWPE/zirconia friction. Clin Mater 1993;12:203-9.
DOI
|
3 |
Catelas I, Petit A, Zukor DJ, Marchand R, Yahia L, Huk OL. Induction of macrophage apoptosis by ceramic and polyethylene particles in vitro. Biomaterials 1999;20:625-30.
DOI
|
4 |
Li J, Liu Y, Hermansson L, Soremark R. Evaluation of biocompatibility of various ceramic powders with human fibroblasts in vitro. Clin Mater 1993;12:197-201.
DOI
|
5 |
Nkamgueu EM, Adnet JJ, Bernard J, Zierold K, Kilian L, Jallot E, Benhayoune H, Bonhomme P. In vitro effects of zirconia and alumina particles on human blood monocyte-derived macrophages: X-ray microanalysis and flow cytometric studies. J Biomed Mater Res 2000;52:587-94.
DOI
|
6 |
Kosmac T, Oblak C, Jevnikar P, Funduk N, Marion L. The effect of surface grinding and sandblasting on flexural strength and reliability of Y-TZP zirconia ceramic. Dent Mater 1999;15:426-33.
DOI
|
7 |
Al-Amleh B, Lyons K, Swain M. Clinical trials in zirconia: a systematic review. J Oral Rehabil 2010;37:641-52.
|
8 |
Manicone PF, Rossi Iommetti P, Raffaelli L, Paolantonio M, Rossi G, Berardi D, Perfetti G. Biological considerations on the use of zirconia for dental devices. Int J Immunopathol Pharmacol 2007;20:9-12.
|
9 |
Josset Y, Oum'Hamed Z, Zarrinpour A, Lorenzato M, Adnet JJ, Laurent-Maquin D. In vitro reactions of human osteoblasts in culture with zirconia and alumina ceramics. J Biomed Mater Res 1999;47:481-93.
DOI
|
10 |
Lohmann CH, Dean DD, Koster G, Casasola D, Buchhorn GH, Fink U, Schwartz Z, Boyan BD. Ceramic and PMMA particles differentially affect osteoblast phenotype. Biomaterials 2002;23:1855-63.
DOI
|
11 |
Sterner T, Schutze N, Saxler G, Jakob F, Rader CP. Effects of clinically relevant alumina ceramic, zirconia ceramic and titanium particles of different sizes and concentrations on TNFalpha release in a human macrophage cell line. Biomed Tech (Berl) 2004;49:340-4.
|
12 |
Tateishi T, Ushida T, Aoki H. Round robin test for standardization of biocompatibility test procedure by cell culture method. Adv Biomater 1992;10:89-97.
|
13 |
Silva VV, Lameiras FS, Lobato ZI. Biological reactivity of zirconia-hydroxyapatite composites. J Biomed Mater Res 2002;63:583-90.
DOI
|
14 |
Carinci F, Pezzetti F, Volinia S, Francioso F, Arcelli D, Farina E, Piattelli A. Zirconium oxide: analysis of MG63 osteoblastlike cell response by means of a microarray technology. Biomaterials 2004;25:215-28.
DOI
|
15 |
Garvie RC, Urbani C, Kennedy DR, McNeuer JC. Biocompatibility of Magnesia Partially Stabilized Zirconia (Mg-PSZ) Ceramics. J Mater Sci 1984;19:3224-8.
DOI
|
16 |
Rimondini L, Cerroni L, Carrassi A, Torricelli P. Bacterial colonization of zirconia ceramic surfaces: an in vitro and in vivo study. Int J Oral Maxillofac Implants 2002;17:793-8.
|
17 |
Covacci V, Bruzzese N, Maccauro G, Andreassi C, Ricci GA, Piconi C, Marmo E, Burger W, Cittadini A. In vitro evaluation of the mutagenic and carcinogenic power of high purity zirconia ceramic. Biomaterials 1999;20:371-6.
DOI
|
18 |
Fassina P, Zaghini N, Bukat A, Piconi C, Greco F, Piantelli S. Yttria and calcia partially stabilized zirconia for biomedical applications. In: Ravaglioli A., Krajewski A, eds. Bioceramics and the human body. Netherlands; Springer; 1992. p. 223-9.
|